Asser Abou Elkassem

109 posts

Asser Abou Elkassem

Asser Abou Elkassem

@Asser_AE

RadRes @UABRadiology ☢ 🏊‍♂️🤽

Birmingham, AL Bergabung Ağustos 2020
179 Mengikuti166 Pengikut
Asser Abou Elkassem me-retweet
Asser Abou Elkassem me-retweet
Susanna I Lee
Susanna I Lee@SusannaLeeRad·
A commercially available tool for opportunistic screening for cardiomegaly on noncontrast chest CT's. Lung cancer screening doesn't have to be just about the lungs! @RSNA @OxfordJournals #RadAdv
Clive Musonza@CliveMusonza_MD

AI-enabled cardiac volumetry can identify cardiomegaly from non-contrast, non-gated chest CT scans with good diagnostic performance and excellent repeatability.​ @RSNA @OxfordJournals @SusannaLeeRaddoi.org/10.1093/radadv…

English
0
3
8
728
Asser Abou Elkassem me-retweet
Susanna I Lee
Susanna I Lee@SusannaLeeRad·
This study collects responses directly from the public on whether they prefer LLM summaries of lung cancer screening reports. They do! And those with the lowest healthcare literacy seem benefit the most. @RSNA @OxfordJournals @UCSFimaging @sohn522
Clive Musonza@CliveMusonza_MD

In a vignette-based survey of U.S. general population, LLM-generated summaries of lung cancer screening reports significantly improved patient comprehension and lowered anxiety especially for those with lower health literacy. ​ @RSNA @OxfordJournals @SusannaLeeRaddoi.org/10.1093/radadv…

English
0
4
7
672
Asser Abou Elkassem me-retweet
Asser Abou Elkassem me-retweet
Susanna I Lee
Susanna I Lee@SusannaLeeRad·
#RadAdv is recruiting trainee editors for the coming academic year. Those interested in helping shape the future of radiology should apply. Deadline is May 3! @rsna @OxfordJournals tinyurl.com/yc68j588
RSNA@RSNA

Applications are open for RSNA Journals Trainee Editorial Boards. Gain real experience in peer review, editing and scientific publishing while building your network in academic radiology. Apply today: bit.ly/3J2GLj3 #RadInTraining

English
0
5
17
3.2K
Asser Abou Elkassem me-retweet
Susanna I Lee
Susanna I Lee@SusannaLeeRad·
For most patients undergoing 90Y-SIRT to treat liver tumors, lung shunt fraction and lung dose are not the limiting factor. This model identifies those cases where MAA SPECT can safely be omitted using the pretreatment CT! @RSNA @OxfordJournals #RadAdv
Huang Juncheng (Jason)@J__Huang

A novel lung shunt fraction (LSF) metric can reliably identify 90Y-SIRT cases where MAA-based LSF determination may be omitted while preserving treatment planning accuracy. @RSNA @OxfordJournals @SusannaLeeRad doi.org/10.1093/radadv…

English
0
1
6
715
Asser Abou Elkassem me-retweet